Capital Point Ltd. (TASE:CPTP) sold 0.79% stake in NeuroDerm Ltd. (NasdaqGM:NDRM) for $3 million on October 5, 2016. Capital Point sold about 0.17 million Neuroderm’s shares for $17.6 per share. The Board and ad-hoc commission of Capital Point approved the transaction. Capital Point Ltd. (TASE:CPTP) completed the sale of 0.79% stake in NeuroDerm Ltd. (NasdaqGM:NDRM) on October 5, 2016.